10 Document Control Mistakes That Trigger FDA 483s

Document control is one of the most frequently cited areas in FDA 483 observations. Many of the findings inspectors record are not the result of major system failures. Rather, they stem from small, preventable gaps that accumulate over time. The following mistakes appear repeatedly across facilities of all sizes.

1. Missing or Incomplete Version Control

SOPs and records with incorrect version numbers, missing revision dates, or obsolete copies still in circulation are a fast path to a 483. Every document must reflect its current, approved state.

2. Signatures Without Dates

An unsigned or undated signature line on a batch record or deviation form tells an inspector that your attestation process is not consistently enforced. Both elements are required and must be completed at the time of the activity.

3. Uncontrolled Copies in Use

When staff print working copies of controlled documents and do not stamp or track them, inspectors cannot confirm that personnel are following the current, approved version.

4. No Evidence of Training on Updated Procedures

Revising an SOP without documenting that affected personnel have been trained on the change is a documentation gap that frequently surfaces during walkdowns.

5. Poorly Defined Approval Chains

Documents that lack a clear, documented approval pathway or that show approvals from individuals without the authority to approve them signal a system without adequate oversight.

6. Change Control Records That Do Not Reference Documents

When a change control record does not explicitly tie back to the documents it affects, or when those documents have not been updated to reflect the change, inspectors see a broken chain of accountability.

7. Legibility Problems

Handwritten entries that cannot be clearly read are an ALCOA+ failure. If an entry cannot be understood without interpretation, it cannot be verified.

8. Forms Used Past Their Effective Date

Using a form that has been superseded by a newer version is a version control violation, even when the information recorded on it is accurate.

9. Document Retrieval Failures During Inspection

Being unable to quickly produce a requested document during an inspection is a red flag. Inspectors expect organized, accessible records. Delays suggest your system lacks adequate indexing or control.

10. No Periodic Review Process

Documents that have not been reviewed for accuracy and applicability within your defined review cycle suggest that your quality system is not actively maintained.

Each of these mistakes is correctable before an inspection ever begins. A document control gap analysis, conducted as part of a routine readiness review, gives your team the opportunity to find and fix these issues before an investigator does.

VaLogic supports pharmaceutical and life sciences manufacturers with document control assessments, SOP development, and inspection readiness consulting. Contact us to learn how we can help you close the gaps before they become observations.